434 related articles for article (PubMed ID: 15128474)
1. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
[No Abstract] [Full Text] [Related]
2. A family physician questions the conclusions from ALLHAT.
Standridge JB
Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
[TBL] [Abstract][Full Text] [Related]
3. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
Cardinal H; Monfared AA; Dorais M; LeLorier J
Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
[TBL] [Abstract][Full Text] [Related]
4. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
5. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
Düsing R
Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
[No Abstract] [Full Text] [Related]
6. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
Xie F; Petitti DB; Chen W
Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive treatment and CHD in the elderly.
Fink KS; Ellsworth A
Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
[No Abstract] [Full Text] [Related]
8. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
[TBL] [Abstract][Full Text] [Related]
9. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
Nicholls MG
J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
[No Abstract] [Full Text] [Related]
10. Treatment of hypertension in patients with diabetes mellitus.
Agarwal R
Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
[No Abstract] [Full Text] [Related]
11. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
[TBL] [Abstract][Full Text] [Related]
12. New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics.
Phillips RA
Arch Intern Med; 2006 Nov; 166(20):2174-6. PubMed ID: 17101933
[No Abstract] [Full Text] [Related]
13. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Beevers DG; Lee KW; Lip GY
J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
[No Abstract] [Full Text] [Related]
14. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
15. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
[TBL] [Abstract][Full Text] [Related]
16. New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial.
Sierra C; Ruilope LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):169-70. PubMed ID: 14608521
[TBL] [Abstract][Full Text] [Related]
17. Letter by barrios et Al regarding article, "heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial".
Barrios V; Escobar C; Echarri R
Circulation; 2009 Aug; 120(5):e31; author reply e32. PubMed ID: 19652116
[No Abstract] [Full Text] [Related]
18. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
19. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
20. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
Elliott WJ
Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
